Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder cancer. Using the immunotherapy drug durvalumab before and after surgery reduced the recurrence of operable bladder cancer by a third,

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click for our IBRX stock update.

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or mpMRI-staged care.

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in the UK

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms might seem minor, understanding

A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being released into the air at rates higher than current legal standards.

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait.

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also being trialled in other cancers.

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or returning when treated with immunosurpressant drug durvalumab, and were more likely to still be alive two years after treatment.

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the disease returning by a third...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait.